Personal information

Other IDs

Scopus Author ID: 51763432400
Scopus Author ID: 57200292130

Countries

Italy

Activities

Collapse all

Employment (6)

Ospedale Policlinico San Martino: Genoa, IT

2022-07-12 to present | Physician (Genetics of Rare Cancers)
Employment
Source: Self-asserted source
Bruna Dalmasso

170011 - UNIVERSITA' DEGLI STUDI DI GENOVA: Genova, Liguria, IT

2019-12-03 to 2019-12-05 | Dottorandi (100007 - Dipartimento di Medicina interna e specialità mediche)
Employment
Source: check_circle
Università degli studi di Genova - IRIS

170011 - UNIVERSITA' DEGLI STUDI DI GENOVA: Genova, Liguria, IT

2019-11-13 to 2019-11-14 | Dottorandi (100007 - Dipartimento di Medicina interna e specialità mediche)
Employment
Source: check_circle
Università degli studi di Genova - IRIS

170011 - UNIVERSITA' DEGLI STUDI DI GENOVA: Genova, Liguria, IT

2016-11-01 to 2019-10-31 | Dottorandi (100007 - Dipartimento di Medicina interna e specialità mediche)
Employment
Source: check_circle
Università degli studi di Genova - IRIS

170011 - UNIVERSITA' DEGLI STUDI DI GENOVA: Genova, Liguria, IT

2012-05-01 to 2014-10-31 | Borsisti (100007 - Dipartimento di Medicina interna e specialità mediche)
Employment
Source: check_circle
Università degli studi di Genova - IRIS

170011 - UNIVERSITA' DEGLI STUDI DI GENOVA: Genova, Liguria, IT

2012-01-01 to 2012-04-30 | Borsisti (48 - Dipartimento di Medicina Interna e Specialita mediche (DIMI) (attivo dal 01/01/1997 al 18/07/2012))
Employment
Source: check_circle
Università degli studi di Genova - IRIS

Education and qualifications (3)

University of Genoa: Genoa, Liguria, IT

2016-11-01 to 2020-05-27 | PhD (Genetics of Eare Cancers, Department of Internal Medicine and Medical Specialties)
Education
Source: Self-asserted source
Bruna Dalmasso

University of Genoa: Genoa, Liguria, IT

2010-04 to 2015-05 | Internal Medicine specialist (Department of Internal Medicine and Medical Specialties)
Education
Source: Self-asserted source
Bruna Dalmasso

University of Genoa: Genoa, Liguria, IT

2003-10 to 2009-07-28 | MD
Education
Source: Self-asserted source
Bruna Dalmasso

Works (30)

Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort

2024-01-01 | Journal article
DOI: 10.1186/s12967-024-05227-2
HANDLE: 11567/1181295
EID:

2-s2.0-85193331326

PMID: 38750555
WOSUID:

WOS:001224137700006
Source: check_circle
Università degli studi di Genova - IRIS

Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients

2024-01-01 | Journal article
DOI: 10.1016/j.ejca.2024.114226
HANDLE: 11567/1202127
EID:

2-s2.0-85198908416

PMID: 39029294
WOSUID:

WOS:001275667900001
Source: check_circle
Università degli studi di Genova - IRIS

Long Non-Coding RNAs and Metabolic Rewiring in Pancreatic Cancer

Cancers
2023-07 | Journal article | Author
DOI: 10.3390/cancers15133486
Contributors: Bruna Dalmasso; Paola Ghiorzo
Source: check_circle
Multidisciplinary Digital Publishing Institute

Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives

Cancers
2023-03 | Journal article | Author
DOI: 10.3390/cancers15072074
Contributors: Fabio Catalano; Malvina Cremante; Bruna Dalmasso; Chiara Pirrone; Agostina Lagodin D’Amato; Massimiliano Grassi; Danila Comandini
Source: check_circle
Multidisciplinary Digital Publishing Institute

Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting

International Journal of Molecular Sciences
2023-02 | Journal article | Author
DOI: 10.3390/ijms24054302
Contributors: Irene Vanni; Lorenza Pastorino; Enrica Teresa Tanda; Virginia Andreotti; Bruna Dalmasso; Nicola Solari; Matteo Mascherini; Francesco Cabiddu; Antonio Guadagno; Simona Coco et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma

International Journal of Molecular Sciences
2022-12 | Journal article | Author
DOI: 10.3390/ijms232416027
Contributors: Lorenza Pastorino; Bruna Dalmasso; Eleonora Allavena; Irene Vanni; Filippo Ugolini; Gianna Baroni; Michela Croce; Antonio Guadagno; Francesco Cabiddu; Virginia Andreotti et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients

Cancers
2022-09 | Journal article | Author
DOI: 10.3390/cancers14184447
Contributors: Alberto Puccini; Marta Ponzano; Bruna Dalmasso; Irene Vanni; Annalice Gandini; Silvia Puglisi; Roberto Borea; Malvina Cremante; William Bruno; Virginia Andreotti et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients

International Journal of Molecular Sciences
2022-04 | Journal article | Author
DOI: 10.3390/ijms23094709
Contributors: Bruna Dalmasso; Alberto Puccini; Fabio Catalano; Roberto Borea; Maria Laura Iaia; William Bruno; Giuseppe Fornarini; Stefania Sciallero; Sara Elena Rebuzzi; Paola Ghiorzo
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup

2022-01-01 | Journal article
DOI: 10.1016/j.esmoop.2022.100525
HANDLE: 11567/1091439
EID:

2-s2.0-85132875373

WOSUID:

WOS:000828209200002
Source: check_circle
Università degli studi di Genova - IRIS

Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants

Cancers
2021-05 | Journal article | Author
DOI: 10.3390/cancers13102440
Contributors: Francesco Spagnolo; Bruna Dalmasso; Enrica Tanda; Miriam Potrony; Susana Puig; Remco van Doorn; Ellen Kapiteijn; Paola Queirolo; Hildur Helgadottir; Paola Ghiorzo
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

First international workshop of the ATM and cancer risk group (4-5 December 2019)

2021-01-01 | Journal article
DOI: 10.1007/s10689-021-00248-y
HANDLE: 11567/1051744
EID:

2-s2.0-85107970671

PMID: 34125377
WOSUID:

WOS:000661358000001
Source: check_circle
Università degli studi di Genova - IRIS

Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia

2021-01-01 | Journal article
DOI: 10.1038/s41436-021-01240-8
HANDLE: 11567/1051736
EID:

2-s2.0-85120623995

PMID: 34262154
WOSUID:

WOS:000673475700001
Source: check_circle
Università degli studi di Genova - IRIS

Disruption of DNA damage response pathways in tumorigenesis: investigating the role of ATM and BAP1 in hereditary cancers.
Source: check_circle
Università degli studi di Genova - IRIS

Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients

2020-01-01 | Journal article
DOI: 10.1186/s12967-020-02253-8
HANDLE: 11567/1009814
EID:

2-s2.0-85079334638

PMID: 32054529
WOSUID:

WOS:000515849900001
Source: check_circle
Università degli studi di Genova - IRIS

Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram

2020-01-01 | Journal article
DOI: 10.1200/JCO.19.01902
HANDLE: 11567/1009808
EID:

2-s2.0-85084379874

PMID: 32167862
WOSUID:

WOS:000537768800010
Source: check_circle
Università degli studi di Genova - IRIS

Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

2020-01-01 | Journal article
DOI: 10.1038/s41588-020-0611-8
HANDLE: 11567/1023896
EID:

2-s2.0-85084007486

PMID: 32341527
WOSUID:

WOS:000529000400001
Source: check_circle
Università degli studi di Genova - IRIS

Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1

2020-01-01 | Journal article
DOI: 10.3390/cancers12041007
HANDLE: 11567/1009635
EID:

2-s2.0-85083959471

PMID: 32325837
WOSUID:

WOS:000535587400235
Source: check_circle
Università degli studi di Genova - IRIS

Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications

2020-01-01 | Journal article
DOI: 10.3389/fmolb.2020.00172
HANDLE: 11567/1023642
EID:

2-s2.0-85089341903

PMID: 32850962
WOSUID:

WOS:000560677100001
Source: check_circle
Università degli studi di Genova - IRIS

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)

2020-01-01 | Journal article
DOI: 10.1186/s13000-020-01052-5
HANDLE: 11567/1033924
EID:

2-s2.0-85097564294

PMID: 33317587
WOSUID:

WOS:000599798200001
Source: check_circle
Università degli studi di Genova - IRIS

Reply to E. Hindié

2020-01-01 | Journal article
DOI: 10.1200/JCO.20.01460
HANDLE: 11567/1023898
EID:

2-s2.0-85091191724

PMID: 32701413
WOSUID:

WOS:000574579100017
Source: check_circle
Università degli studi di Genova - IRIS

Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204

Oncotarget
2018 | Journal article
DOI: 10.18632/oncotarget.25684
EID:

2-s2.0-85048829945
Contributors: Bruno, W.; Martinuzzi, C.; Dalmasso, B.; Andreotti, V.; Pastorino, L.; Cabiddu, F.; Gualco, M.; Spagnolo, F.; Ballestrero, A.; Queirolo, P. et al.
Source: Self-asserted source
Bruna Dalmasso via Scopus - Elsevier
grade
Preferred source (of 2)‎

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

Journal of the National Cancer Institute
2018-12-01 | Journal article
DOI: 10.1093/jnci/djy171
PMID: 30517737
Source: Self-asserted source
Bruna Dalmasso
grade
Preferred source (of 3)‎

Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy.

BMC cancer
2018-10-22 | Journal article
DOI: 10.1186/s12885-018-4920-6
PMID: 30348127
PMC: PMC6196565
Source: Self-asserted source
Bruna Dalmasso
grade
Preferred source (of 3)‎

CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients.

Journal of the American Academy of Dermatology
2018-09-28 | Journal article
DOI: 10.1016/j.jaad.2018.07.060
PMID: 30274933
Source: Self-asserted source
Bruna Dalmasso
grade
Preferred source (of 3)‎

Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry

ONCOTARGET
2017 | Journal article
DOI: 10.18632/oncotarget.14094
Source: Self-asserted source
Bruna Dalmasso
grade
Preferred source (of 3)‎

Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations.

Oncotarget
2017-12-14 | Journal article
DOI: 10.18632/oncotarget.23204
PMID: 29464027
PMC: PMC5814167
Source: Self-asserted source
Bruna Dalmasso
grade
Preferred source (of 2)‎

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters

ONCOTARGET
2016 | Journal article
DOI: 10.18632/oncotarget.8796
Source: Self-asserted source
Bruna Dalmasso
grade
Preferred source (of 3)‎

Biological ageing and frailty markers in breast cancer patients

AGING
2015 | Journal article
DOI: 10.18632/aging.100745
Source: Self-asserted source
Bruna Dalmasso
grade
Preferred source (of 3)‎

Circulating MicroRNAs as easy-to-measure aging biomarkers in older breast cancer patients: Correlation with chronological age but not with fitness/frailty status

PLOS ONE
2014 | Journal article
DOI: 10.1371/journal.pone.0110644
Source: Self-asserted source
Bruna Dalmasso
grade
Preferred source (of 3)‎

An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: Preliminary results on tolerability and clinical effects

ANNALS OF GENERAL PSYCHIATRY
2011 | Journal article
DOI: 10.1186/1744-859X-10-23
Source: Self-asserted source
Bruna Dalmasso
grade
Preferred source (of 3)‎
How many people are using ORCID?